ORIC Pharmaceuticals Stock Forecast

Stock Price Forecast

The 10 analysts with 12-month price forecasts for ORIC Pharmaceuticals stock have an average target of 20.2, with a low estimate of 14 and a high estimate of 25. The average target predicts an increase of 111.96% from the current stock price of 9.53.

Analyst Consensus: Strong Buy

Target	Low	Average	Median	High
Price	$14	$20.2	$22	$25
Change	+46.90%	+111.96%	+130.85%	+162.33%

Analyst Ratings

The average analyst rating for ORIC Pharmaceuticals stock from 17 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Rating	Jan '26	Feb '26	Mar '26	Apr '26	May '26	Jun '26
Strong Buy	12	12	12	12	13	14
Buy	2	2	2	2	2	2
Hold	1	1	1	1	1	1
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	15	15	15	15	16	17

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Kelsey Goodwin Piper Sandler	Piper Sandler	Buy Maintains $22	Buy	Maintains	$22	+130.85%	Jun 29, 2026
Robert Burns H.C. Wainwright	H.C. Wainwright	Buy Reiterates $25	Buy	Reiterates	$25	+162.33%	Jun 24, 2026
Laura Prendergast Stifel Nicolaus	Stifel Nicolaus	Buy Initiates $14	Buy	Initiates	$14	+46.90%	Jun 11, 2026
Derek Archila Wells Fargo	Wells Fargo	Buy Reiterates $25	Buy	Reiterates	$25	+162.33%	Jun 11, 2026
Corinne Johnson Goldman Sachs	Goldman Sachs	Buy Reiterates $15	Buy	Reiterates	$15	+57.40%	Jun 3, 2026

More Analyst Ratings

Financial Forecast

Revenue This Year

n/a

Revenue Next Year

n/a

EPS This Year

-1.46

from -1.47

EPS Next Year

-1.57

from -1.46

Fiscal Year	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026	FY 2027
Period Ending	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026	Dec 31, 2027
Revenue	-	-	-	-	-	-	-
Revenue Growth	-	-	-	-	-	-	-
EPS	-2.07	-2.25	-1.96	-1.83	-1.47	-1.46	-1.58
EPS Growth	-	-	-	-	-	-	-
Forward PE	-	-	-	-	-	-	-
No. Analysts	-	-	-	-	-	13	11

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2026	2027
High	n/a	n/a
Avg	n/a	n/a
Low	n/a	n/a

Revenue Growth

Revenue Growth	2027	2028
High	-	-
Avg	-	-
Low	-	-

EPS Forecast

EPS	2026	2027
High	-1.30	-1.20
Avg	-1.46	-1.57
Low	-1.66	-1.86

EPS Growth

EPS Growth	2026	2027
High	-	-
Avg	-	-
Low	-	-

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.